A detailed history of Cic Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cic Wealth, LLC holds 3,237 shares of VRTX stock, worth $1.5 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
3,237
Previous 3,172 2.05%
Holding current value
$1.5 Million
Previous $1.49 Billion 1.26%
% of portfolio
0.39%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$460.0 - $505.78 $29,900 - $32,875
65 Added 2.05%
3,237 $1.51 Billion
Q2 2024

Jul 12, 2024

SELL
$392.81 - $485.53 $98,202 - $121,382
-250 Reduced 7.31%
3,172 $1.49 Billion
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $299,244 - $327,422
734 Added 27.31%
3,422 $1.43 Billion
Q4 2023

Jan 11, 2024

BUY
$343.0 - $410.68 $921,984 - $1.1 Million
2,688 New
2,688 $1.09 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cic Wealth, LLC Portfolio

Follow Cic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cic Wealth, LLC with notifications on news.